Atlas Trials

A Study to Assess Pharmacokinetics of Preladenant in Participants With Chronic Hepatic Impairment (P06513)

Clinical trial NCT01465412 · COMPLETED

Trial details

NCT number
NCT01465412
Sponsor
Merck Sharp & Dohme LLC
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Chronic Hepatic Impairment
Start date
2011-11-10
Primary completion
2012-06-14
Enrollment
42

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.